AI-generated analysis. Always verify with the original filing.
Cross Country Healthcare, Inc. announced Q4 and full year 2025 financial results, reporting revenue of $236.8 million and $1.1 billion respectively, a net loss of $82.9 million and $94.9 million driven by $77.9 million goodwill impairment and $29.6 million valuation allowance, with Adjusted EBITDA of $4.1 million and $26.8 million. The company provided Q1 2026 guidance for revenue of $235-240 million and Adjusted EBITDA of $4.0-5.0 million.
Event Type
Disclosure
Mandatory
Variant
8-K
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such sec
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such sec
Financial Statements and Exhibits (d) Exhibits Exhibit Description 99.1 Press Release issued by the Company on March 4 , 202 6 104 Cover Page Interactive Data F
| Metric | Value | Basis |
|---|---|---|
| Revenue | $236.8K | |
| Gross profit margin | 20.3% | |
| Net loss attributable to common stockholders | $-82.9K | GAAP |
| Diluted EPS | $-2.56 | GAAP |
| Adjusted EBITDA | $4.1K | Non-GAAP |
| Adjusted EPS | $-0.06 | Non-GAAP |
Revenue
235-240
Adjusted EBITDA
4.0-5.0
Non-GAAP
Adjusted EPS
-0.06 to -0.04
Non-GAAP
Buyback Auth.
34000000